Author: Heinert, Sara W.; McCoy, Jonathan; Eisenstein, Robert; Rowley, Jessica
Title: Reaching the hard to reach: Characteristics of patients who received a COVIDâ€19 vaccine in the emergency department Cord-id: tfdr455l Document date: 2021_8_26
ID: tfdr455l
Snippet: In February 2021, the U.S. Food and Drug Administration (FDA) provided Emergency Use Authorization for the Janssen vaccine- the first one-dose COVID-19 vaccine to become available in the U.S. The one-dose regimen expanded opportunity to vaccinate in settings that can reach vulnerable communities for which returning to a site for a second vaccine dose may prove difficult. With 139 million visits annually in the U.S.1 and a tendency to serve in a safety net capacity for underserved patients2 , the
Document: In February 2021, the U.S. Food and Drug Administration (FDA) provided Emergency Use Authorization for the Janssen vaccine- the first one-dose COVID-19 vaccine to become available in the U.S. The one-dose regimen expanded opportunity to vaccinate in settings that can reach vulnerable communities for which returning to a site for a second vaccine dose may prove difficult. With 139 million visits annually in the U.S.1 and a tendency to serve in a safety net capacity for underserved patients2 , the emergency department (ED) is one such setting.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date